rs28617395
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_005428.4(VAV1):c.322-8C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.149 in 1,613,840 control chromosomes in the GnomAD database, including 19,113 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_005428.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VAV1 | NM_005428.4 | c.322-8C>T | splice_region_variant, intron_variant | ENST00000602142.6 | NP_005419.2 | |||
VAV1 | NM_001258206.2 | c.322-8C>T | splice_region_variant, intron_variant | NP_001245135.1 | ||||
VAV1 | NM_001258207.2 | c.322-8C>T | splice_region_variant, intron_variant | NP_001245136.1 | ||||
VAV1 | XM_005259642.2 | c.322-8C>T | splice_region_variant, intron_variant | XP_005259699.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VAV1 | ENST00000602142.6 | c.322-8C>T | splice_region_variant, intron_variant | 1 | NM_005428.4 | ENSP00000472929.1 |
Frequencies
GnomAD3 genomes AF: 0.128 AC: 19485AN: 152018Hom.: 1404 Cov.: 32
GnomAD3 exomes AF: 0.125 AC: 31453AN: 251296Hom.: 2251 AF XY: 0.128 AC XY: 17423AN XY: 135826
GnomAD4 exome AF: 0.151 AC: 221210AN: 1461706Hom.: 17701 Cov.: 35 AF XY: 0.151 AC XY: 109542AN XY: 727154
GnomAD4 genome AF: 0.128 AC: 19510AN: 152134Hom.: 1412 Cov.: 32 AF XY: 0.125 AC XY: 9281AN XY: 74364
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 28, 2023 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
VAV1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 21, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at